Shree Ganesh Biotech India standalone net profit rises 3366.67% in the March 2022 quarter

Shree Ganesh Biotech shares surged more than 5% on the BSE in Thursday’s deals after bonus shares issue announcement

Shree Ganesh Biotech India to consider bonus shares issue, stock surges

Shree Ganesh Biotech India standalone net profit rises 1750.00% in the December 2020 quarter

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

The Company produces, processes and markets hybrids of crops, such as corn, sunflower, cotton and grain sorghum etc. It is also engaged in commercial production of large cardamom, banana (G9), teak plant & ginger.